Anna DeFazio

40.7k total citations · 4 hit papers
123 papers, 6.5k citations indexed

About

Anna DeFazio is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Anna DeFazio has authored 123 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Reproductive Medicine, 56 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Anna DeFazio's work include Ovarian cancer diagnosis and treatment (60 papers), Cancer Genomics and Diagnostics (14 papers) and BRCA gene mutations in cancer (12 papers). Anna DeFazio is often cited by papers focused on Ovarian cancer diagnosis and treatment (60 papers), Cancer Genomics and Diagnostics (14 papers) and BRCA gene mutations in cancer (12 papers). Anna DeFazio collaborates with scholars based in Australia, United States and United Kingdom. Anna DeFazio's co-authors include David D.L. Bowtell, Sián Fereday, Penelope M. Webb, Joshy George, R. Sutherland, Stephen B. Fox, Yoke-Eng Chiew, C. K. W. Watts, Dariush Etemadmoghadam and Michael Friedländer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Anna DeFazio

114 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

2008 1.0k citations Richard W. Tothill, Anna V. Tinker et al. Clinical Cancer Research profile →
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

2012 853 citations Kathryn Alsop, Sián Fereday et al. profile →
Expression and amplification of cyclin genes in human breast cancer.

1993 583 citations Anna DeFazio, C. K. W. Watts et al. profile →
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

2010 508 citations Ahmed A. Ahmed, Dariush Etemadmoghadam et al. The Journal of Pathology profile →

Peers

Countries citing papers authored by Anna DeFazio

Since Specialization

Citations

This map shows the geographic impact of Anna DeFazio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna DeFazio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna DeFazio more than expected).

Fields of papers citing papers by Anna DeFazio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna DeFazio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna DeFazio. The network helps show where Anna DeFazio may publish in the future.

Co-authorship network of co-authors of Anna DeFazio

This figure shows the co-authorship network connecting the top 25 collaborators of Anna DeFazio. A scholar is included among the top collaborators of Anna DeFazio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna DeFazio. Anna DeFazio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants 2025 ·European Journal of Human Genetics ·David Goldsbury, Yoon‐Jung Kang, Catherine Tang, (unknown), Amelia K. Smit, Kate Dunlop, Lara Petelin, (unknown), (unknown), Nicola S. Meagher, Melissa A. Merritt, Marianne Weber, Anna DeFazio, Anne Ε. Cust, Karen Canfell, Julia Steinberg	0
2	Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival? 2024 ·Gynecologic Oncology ·(unknown), Renhua Na, George Au‐Yeung, Anna DeFazio, Michael Friedländer, (unknown), (unknown), Christina M. Nagle, (unknown), (unknown), Penelope M. Webb, Vanessa L. Beesley	0
3	Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study 2023 ·JNCI Journal of the National Cancer Institute ·Azam Majidi, Renhua Na, Susan J. Jordan, Anna DeFazio, Andreas Obermair, Michael Friedländer, Peter Grant, Penelope M. Webb	6
4	Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma 2023 ·Translational Oncology ·(unknown), Yeh Chen Lee, Hao‐Wen Sim, (unknown), (unknown), Judy Kirk, Paul R. Harnett, Rosemary L. Balleine, David D.L. Bowtell, Goli Samimi, Alison H. Brand, Deborah J. Marsh, Philip Beale, Lyndal Anderson, (unknown), Pamela Provan, Susan J. Ramus, Anna DeFazio, Michael Friedländer	0
5	Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study 2022 ·Supportive Care in Cancer ·(unknown), (unknown), Linda Mileshkin, Richard W. Tothill, David D.L. Bowtell, Stephen Quinn, Anna DeFazio, Christos S. Karapetis, Nicholas Wilcken, Madhu Singh, Christopher Steer, Bo Gao, Mark Warren, Ian Collins, Narayan Karanth, (unknown), Penelope Schofield	4
6	Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan 2022 ·Journal of Gynecologic Oncology ·Hung‐Hsueh Chou, Sián Fereday, Anna DeFazio, Chih‐Long Chang, David D.L. Bowtell, Heng‐Cheng Hsu, Nadia Traficante, Soo Jeong, Wen‐Fang Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), David Brown, Byoung‐Gie Kim	2
7	Pre- and Post-Diagnosis Diet Quality and Ovarian Cancer Survival 2020 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Christina M. Nagle, Torukiri I Ibiebele, Peter Grant, Michael Friedländer, Anna DeFazio, Penelope M. Webb	18
8	Going to extremes: determinants of extraordinary response and survival in patients with cancer 2019 ·Nature reviews. Cancer ·(unknown), Alan Herschtal, Brad H. Nelson, Anna DeFazio, Ellen L. Goode, Susan J. Ramus, Ahwan Pandey, Jessica A. Beach, Sián Fereday, Andrew Berchuck, Stéphanie Lheureux, Celeste Leigh Pearce, Paul D.P. Pharoah, Malcolm C. Pike, Dale W. Garsed, David D.L. Bowtell	24
9	Does physical activity improve chemotherapy completion in women receiving chemotherapy for ovarian cancer 2019 ·Asia-Pacific Journal of Clinical Oncology ·Vanessa L. Beesley, (unknown), (unknown), (unknown), George Au‐Yeung, Christina M. Nagle, Anna DeFazio, Peter J. Grant, Andreas Obermair, Michael Friedländer, Penelope M. Webb	0
10	A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers 2016 ·Cancer Research ·MoonSun Jung, Amanda J. Russell, Bing Liu, Joshy George, (unknown), Tao Liu, Anna DeFazio, David D.L. Bowtell, André Oberthuer, Wendy B. London, Jamie I. Fletcher, Michelle Haber, Murray D. Norris, Michelle J. Henderson	75
11	Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations 2013 ·Clinical Cancer Research ·Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, (unknown), Thomas Mikeska, Alexander Dobrovic, Anna DeFazio, (unknown), Gordon K. Smyth, Douglas A. Levine, Gillian Mitchell, David D.L. Bowtell	67
12	Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification? 2011 ·Clinical Cancer Research ·Sally M. Hunter, Michael S. Anglesio, Raghwa Sharma, C. Blake Gilks, Nataliya Melnyk, Yoke-Eng Chiew, Anna DeFazio, Teri A. Longacre, David G. Huntsman, Kylie L. Gorringe, Ian Campbell	17
13	DNA of mouse mammary tumor virus‐like virus is present in human tumors influenced by hormones 2010 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), (unknown), (unknown), Paul Cozzi, Anna DeFazio, William D. Rawlinson	25
14	Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary breakdown → 2010 ·The Journal of Pathology ·Ahmed A. Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G. Lynch, Mohamed Riad, Raghwa Sharma, Colin J.R. Stewart, Sián Fereday, Carlos Caldas, Anna DeFazio, David D.L. Bowtell, James D. Brenton	508
15	ABCB1 ( MDR 1 ) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy 2008 ·Clinical Cancer Research ·Sharon E. Johnatty, Jonathan Beesley, James Paul, Sián Fereday, Amanda B. Spurdle, Penelope M. Webb, Karen Byth, Sharon Marsh, Howard L. McLeod, (unknown), Paul R. Harnett, Robert Brown, Anna DeFazio, Georgia Chenevix‐Trench	73
16	Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors 2008 ·Molecular Cancer Research ·Michael S. Anglesio, Jeremy M. Arnold, Joshy George, Anna V. Tinker, Richard W. Tothill, Nicola Waddell, Lisa A. Simms, Bianca Locandro, Sián Fereday, Nadia Traficante, Peter Russell, Raghwa Sharma, Michael J. Birrer, (unknown), Anna DeFazio, Georgia Chenevix‐Trench, David D.L. Bowtell	91
17	Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome breakdown → 2008 ·Clinical Cancer Research ·Richard W. Tothill, Anna V. Tinker, Joshy George, Robert Brown, Stephen B. Fox, Stephen Lade, Daryl Johnson, Melanie Trivett, Dariush Etemadmoghadam, Bianca Locandro, Nadia Traficante, Sián Fereday, Jillian A. Hung, Yoke-Eng Chiew, Izhak Haviv, (unknown), Dorota M. Gertig, Anna DeFazio, David D.L. Bowtell	1041
18	Scientists and clinicians test their metal–back to the future with platinum compounds 2002 ·The Lancet Oncology ·Alexander Guminski, Paul R. Harnett, Anna DeFazio	21
19	Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines 2000 ·International Journal of Cancer ·Anna DeFazio, Yoke-Eng Chiew, (unknown), Peter W. Janes, Robert L. Sutherland	116
20	Inhibition of DNA Binding and Transcriptional Activity of a Nuclear Receptor Transcription Factor by Aurothiomalate and Other Metal Ions 1991 ·Molecular Pharmacology ·M. Händel, Anna DeFazio, C. K. W. Watts, Richard O. Day, R. Sutherland	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact